(a) There is established within the Office of the Commissioner of Health the Prescription Drug Monitoring Program Advisory Committee to consult with and advise the Department on matters related to the establishment, maintenance, operation, and evaluation of the Program.
(b) The Committee consists of five voting members and the Commissioner, or a designee, who shall serve as a non-voting chairperson. The voting members of the Committee are:(1) a mental health provider or certified drug and alcohol counselor; and(2) one representative designated by each of the following organizations:(A) Virgin Islands Board of Medical Examiners;(B) Virgin Islands Board of Pharmacy;(C) Virgin Islands Department of Justice; and(D) Virgin Islands Territorial Public Defender Office.
(1) a mental health provider or certified drug and alcohol counselor; and
(2) one representative designated by each of the following organizations:(A) Virgin Islands Board of Medical Examiners;(B) Virgin Islands Board of Pharmacy;(C) Virgin Islands Department of Justice; and(D) Virgin Islands Territorial Public Defender Office.
(A) Virgin Islands Board of Medical Examiners;
(B) Virgin Islands Board of Pharmacy;
(C) Virgin Islands Department of Justice; and
(D) Virgin Islands Territorial Public Defender Office.
(c) Each member shall serve a three-year term or until the appointment of the member’s successor.
(d) Three voting members of the Committee constitute a quorum. Actions of the Committee are adopted when a majority of the members vote in favor of the action.
(e) The Committee shall hold not less than four meetings per year, or more often upon the call of a meeting by the chairperson or the majority of the members.
(f) Members may attend meetings in person, remotely by audiovisual means, or by audio-only.
(g) The Department shall provide staff assistance to the Committee.
(h) Members receive no compensation but must be reimbursed for their actual and necessary expenses incurred in the performance of their duties.